Introduction

• Title
• Disclaimer
• Certification
• Research Overview and Background
• 360 Degree Perspective and the Complex Business Universe
• Table of Contents

Global Perspective

• Global Perspective
• Shifting Global Clinical Trial Dynamics
• Shift In Growth From Mature Markets To Emerging Markets

Integrated Industry Perspective

• Integrated Industry Perspective
• Adaptation To Changing Business Models
• Consolidation of Pfizer and Wyeth
• Convergence of Healthcare Allows for Personalization
• Move from Transactional to Strategic Outsourcing Partnerships Encourages Standardization of LIMS

Technology Perspective

• Technology Perspective
• Oral Oncology Drugs Increasing in Importance
• Advances in Genomics Promotes Healthcare Paradigm Shift
• Effective Screening Methods to Select the Most Promising Drug Candidates
• Growth of Vaccines Market Boosting Technology Innovation
• Gene Therapy Driving Market

Economic Perspective

• Economic Perspective
• Venture Capital Investment in U.S. Biotechnology has Decreased to Levels Not Seen Since 2002
• Decreasing Number of Biotech IPO's due to Economic Downturn
• Restructuring
• Continued Healthcare Spending Growth

Competitive Perspective

• Competitive Perspective
• Companies Transforming to Comprehensive Solution Providers
• Repositioning of Platform Technology Providers in Response to Biomarker Discovery and Diagnostics Development
• Expansion of Biosimilars Alters Industry Landscape

Customer Perspective

• Customer Perspective
• Power Patient Generation
• eDetailing To Assume More Significance
• Medical Tourism – Emerging Hot Spots

Best Practices Perspective

• Best Practices Perspective
• Green Chemistry Initiatives
• Focus on Diseases with High Unmet Needs and Special Designations
• Lower Cost Drugs for Developing Countries
• Employing Hybrid Business Models

About Frost & Sullivan

• Frost & Sullivan